Abstract
Epidemiologic studies have linked dioxin exposure to increased mortality caused by ischemic heart disease. To test the hypothesis that dioxin exposure may constitute an environmental risk factor for atherosclerosis, we exposed C57BL/6J mice to 5 μg/kg of dioxin daily for 3 d, and measured various molecular and physiological markers of heart disease. Dioxin treatment led to an increase in the urinary excretion of vasoactive eicosanoids and an elevation in the mean tail-cuffblood pressure. In addition, dioxin exposure led to an increase in triglycerides, but not in high-density lipoproteins, in both Apoe(+/+) mice and in hyperlipidemic Apoe(−/−) mice. Dioxin exposure also led to an increase in low-density lipoproteins in Apoe(−/−) mice. After treatment, dioxin was associated with low-density lipoprotein particles, which might serve as a vehicle to deliver the compound to atherosclerotic plaques. Dioxin treatment of vascular smooth-muscle cells taken from C57Bl/6J mice resulted in the deregulation of several genes involved in cell proliferation and apoptosis. Subchronic treatment of Apoe(−/−) mice with dioxin (150 ng/kg, three times weekly) for 7 or 26 wk caused a trend toward earlier onset and greater severity of atherosclerotic lesions compared to those of vehicle treated mice. These results suggest that dioxin may increase the incidence of ischemic heart disease by exacerbating its severity.
Similar content being viewed by others
References
Anonymous. (1992). Trends in ischemic heart disease mortality—United States, 1980–1988. Mortal. Morbid. Weekly Rep. 41:548–556.
Ross, R. (1995). Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:791–804.
Kaufman D. W., Helmrich, S. P., Rosenberg, L., Miettinen, O. S., and Shapiro, S. (1983). Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N. Engl. J. Med. 308:409–413.
Poland, A. and Knutson, J. C. (1982). 2,3,7,8,-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanisms of toxicity. Annu. Rev. Pharmacol. Toxicol. 22:517–554.
Nebert, D. W. (1989). The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20:153–174.
Landers, J. P. and Bunce, N. J. (1991). The Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 276:273–287.
Birnbaum, L. S. (1994) The mechanism of dioxin toxicity: relationship to risk assessment. Environ. Health Perspect. 102(Suppl. 9):157–167.
Fingerhut, M. A., Halperin, W. E., Marlow, D. A., et al. (1991). Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N. Engl. J. Med. 324:212–218.
Manz, A., Berger, J., Dwyer, J. H., Flesch-Janys D., Nagel, S., and Waltsgott, H. (1991). Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet 338:959–964.
Flesch-Janys D., Berger, J., Gurn, P., et al. (1995). Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producting plant in Hamburg, Federal Republic of Germany. Am. J. Epidemiol. 142:1165–1175.
DeVito, M. J., Birnbaum, L. S., Farland, W. H., and Gasiewicz, T. A. (1995). Comparisons of estimated human body burdens of dioxin-like chemicals and TCDD body burdens in experimentally exposed animals. Environ. Health Perspect. 103:820–831.
Aviram, M. (1983). Lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30:111–118.
Ramos, K. and Cox, L. R. (1987) Primary cultures of rat aortic endothelial and smooth muscle cells: I. An in vitro model to study xenobiotic-induced vascular cytotoxicity. In Vitro Cell Dev. Biol. 23:288–296.
Capdevila, J. H., Falck, J. R., and Estabrook, R. W. (1992). Cytochrome P450 and the arachidonate cascade. FASEB J. 6:731–736.
Puga, A., Hoffer, A., Zhou, S., Bohm, J. M., Leikauf, G. D., and Shertzer, H. G. (1997). Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem. Pharmacol. 54:1287–1296.
Puga, A., Bohm, J., Hoffer, A., Leikauf, G. D., Shertzer, H. G., and Zhou, S. (1995). Dioxin alters calcium homeostasis and the regulation of arachidonate metabolism in mouse hepatoma cells. Proc. 15th Int. Symp. Chlor. Dioxins 25:381–386.
Kraemer, S. A., Arthur, K. A., Denison, M. S., Smith, W. L., and DeWitt, D. L. (1996) Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8,-tetrachlorodibenzo-p-dioxin. Arch. Biochem. Biophys. 330: 319–328.
Moffat, M. P., Ward, C. A., Bend, J. R., Mock, T., Farhangkhoee, P., and Karmazyn, M. (1993). Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. Am. J. Physiol. 264:H1154-H1160.
Diliberto, J. J., Akubue, P. I., Luebke, R. W., and Birnbaum, L. S. (1995). Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Toxicol. Appl. Pharmacol. 130:197–208.
Kedderis, L. B., Diliberto, J. J., and Birnbaum, L. S. (1991). disposition and excretion of intravenous 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in rats. Toxicol. Appl. Pharmacol. 108:397–406.
Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., and Maeda, N. (1992). Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA 89:4471–4475.
Plump, A. S., Smith, J. D., Hayek, T., et al. (1992). Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343–353.
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., and Maeda, N. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 467–471.
Mahley, R. W. (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622–630.
Birnbaum, L. S. (1995). Developmental effects of dioxins. Environ. Health Perspect. 103(Suppl. 7):89–94.
Lucier, G. W., Portier, C. J., and Gallo, M. A. (1993). Receptor mechanisms and dose-response models for the effects of dioxins. Environ. Health Perspect. 101:36–44.
Paigen, B., Holmes, P. A., Morrow, A., and Mitchell, D. M. (1986). Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors. Cancer Res. 46:3321–3329.
Yao, Y., Hoffer, A., Chang, C.-Y., and Puga, A. (1995). Dioxin activates human immunodeficiency virus type 1 gene expression by an oxidative stress pathway that requires a functional cytochrome P450 CYP1A1 enzyme. Environ. Health Perspect. 103:366–371.
Shertzer, H. G., Nebert, D. W., Puga, A., et al. (1998). TCDD causes a sustained oxidative stress response in C57BL/6J mice. Biochem. Biophys. Res. Commun. 253:44–48.
Puga, A., Barnes, S. J., Chang, C., et al. (2000). Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 59:997–1005.
Park, J. Y., Shigenaga, M. K., and Ames, B. N. (1996). Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage. Proc. Natl. Acad. Sci. USA 19:2322–2327.
Nebert, D. W. and Gonzalez, F. J. (1987). P450 genes. Structure, evolution and regulation. Annu. Rev. Biochem. 56:945–993.
Capdevila, J., Chacos, N., Werringloer, J., Prough, R. A., and Estabrook, R. W. (1981). Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc. Natl. Acad. Sci. USA 78:5362–5366.
Capdevila, J., Karara, A., Waxman, D. J., Martin, M. V., Falck, J. R., and Guengerich, F. P. (1990). Cytochrome P-450 enzyme-specific control of the regio and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J. Biol. Chem. 265:10,865–10,871.
Capdevila, J., Falck, J. R., and Estabrook, R. W. (1992). Cytochrome P450 and the arachidonate cascade. FASEB J. 6:731–736.
Kanetoshi, A., Ward, A. M., May, B. K., and Rifkind, A. B. (1992). Immunochemical identity of the 2,3,7,8-tetra-chlorodibenzo-p-dioxin and beta-naphthoflavone-induced cytochrome P-450 arachidonic acid epoxygenases in chick embryo liver: distinction from the omega-hydroxylase and the phenobarbital-induced epoxygenase. Mol. Pharmacol. 42:1020–1026.
Nakai, K., Ward, A. M., Gannon, M., and Rifkind, A. B. (1992). Beta-naphthoflavone induction of a cytochrome P-450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital-induced arachidonate epoxygenase. J. Biol. Chem. 267:19,503–19,512.
Rifkind, A. B., Lee, C., Chang, T. K., and Waxman, D. J. (1995). Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch. Biochem. Biophys. 320:380–389.
Canga, L., Levi, R., and Rifkind, A. B. (1988). Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: decreased beta-adrenergic responsiveness and evidence of increased intracellular calcium. Proc. Natl. Acad. Sci. USA 85:905–909.
Canga, L., Paroli, L., Blanck, T. J., Silver, R. B., and Rifkind, A. B. (1993). 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts. Mol. Pharmacol. 44:1142–1151.
VanRollins, M., Kaduce, T. L., Fang, X., and Knapp, H. R. (1996). Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells. J. Biol. Chem. 271: 14,001–14,009.
Klausner, J. M., Paterson, I. S., Kobzik, L., Valeri, C. R., Shepro, D., and Hechtman, H. B. (1989). Leukotrienes but not complement mediate limb ischemia-induced lung injury. Ann. Surg. 209:462–470.
Goldman, G., Welbourn, R., Klausner, J. M., et al. (1992). Mast cells and leukotrienes mediate neutrophil sequestration and lung edema after remote ischemia in rodents. Surgery 112:578–586.
Lusis, A.J. and Navab, M. (1993). Lipoprotein oxidation and gene expression in the arterial wall. Biochem. Pharmacol. 46:2119–2126.
Umans, J.G. and Levi, R. (1995). Nitric oxide in the regulation of blood flow and arterial pressure. Annu. Rev. Physiol. 57:771–790.
Khatsenko, O.G., Gross, S.S., Rifkind, A.B., and Vane, J.R. (1993). Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. USA 90:11,147–11,151.
Stadler, J., Trockfeld, J., Schmalix, W.A., et al. (1994). Inhibition of cytochromes P450 1A by nitric oxide. Proc. Natl. Acad. Sci. USA 91:3559–3563.
Puga, A., RayChaudhuri, B., Salata, K., Zhang, Y.-H., and Nebert, D.W. (1990). Stable expression of mouse Cypla-1 and human CYPIA-2 cDNAs transfected into mouse hepatoma cells lacking detectable P450 enzyme activity. DNA Cell Biol. 9:425–436.
RayChaudhuri, B., Nebert, D.W., and Puga, A. (1990). The murine Cypla-1 gene negatively autoregulates its own transcription and that of other members of the aromatic hydrocarbon-responsive [Ah] gene battery. Mol. Endocrinol. 4:1773–1781.
Swift, L.L., Gasiewicz, T.A., Dunn, G.D., Soule, P.D., and Neal, R.A. (1981). Characterization of the hyperlipidemia in guinea pigs induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 59:489–499.
Brewster, D.W., Bombick, D.W., and Matsumura, F. (1988). Rabbit serum hypertriglyceridemia after administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Toxicol. Environ. Health. 25:495–507.
Grubbs, W.D., Wolfe, W.H., Michalek, J.E., et al. (1995). Air Force Health Study. An epidemiologic investigation of health effects in Air Force personnel following exposures to herbicides. 1992 followup examination results. Epidemiologic Research Division. Human Systems Center. Air Force Medical Corps.
Giachelli, C.M., Majesky, M.W., and Schwartz, S.M. (1991). Developmentally regulated cytochrome P450-1A1 expression in cultured rat vascular smooth muscle cells. J. Biol. Chem. 266:3981–3986.
Sadhu, D.N., Merchant, M., Safe, S.H., and Ramos, K.S. (1993). Modulation of protooncogene expression in rat aortic smooth muscle cells by benzo[a]pyrene. Arch. Biochem. Biophys. 300:124–131.
Ramos, K.S. and Parrish, A.R. (1995). Growth-related signaling as a target of toxic insult in vascular smooth muscle cells: implications in atherogenesis. Life Sci. 57:627–635.
Enan, E. and Matsumura, F. (1995). Regulation by 2,3,7,8-tetrachloribenzo-p-dioxin (TCDD) of the DNA binding activity of transcriptional factors via nuclear protein phosphorylation in guinea pig adipose tissue. Biochem. Pharmacol. 50:1199–1206.
Pollenz, R.S. (1996). The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and non-hepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 49:391–398.
Farin, F.M., Pohlman, T.H., and Omiecinski, C.J. (1994). Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicol. Appl. Pharmacol. 124:1–9.
Stegeman, J.J., Miller, M.R., and Hinton, D.E. (1989). Cytochrome P4501A1 induction and localization in endothelium of vertebrate (teleost) heart. Mol. Pharmacol. 36: 723–729.
Raines, E.W. and Ross, R. (1995). Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. J. Nutr. 125:624S-630S.
Elferink, C.J., Ge, N.L., and Levine, A. (2001). Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Mol. Pharmacol. 59: 664–673.
Puga, A., Barnes, S.J., Dalton, T.P., Chang, C., Knudsen, E.S., and Maier, M.A. (2000). Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J. Biol. Chem. 275:2943–2950.
Puga, A., Maier, A., and Medvedovic, M. (2000). The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem. Pharmacol. 60:1129–1142.
Strobeck, M.W., Fribourg, A.F., Puga, A., and Knudsen, E.S. (2000). Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene 19: 1857–1867.
Reiners, J.J. Jr. and Clift, R.E. (1999). Aryl hydrocarbon receptor regulation of ceramide-induced apoptosis in murine hepatoma 1c1c7 cells. J. Biol. Chem. 274:2502–2510.
Ge, N.-L. and Elferink, C.J. (1998). A direct interaction between the aryl hydrocarbon receptor and retinoblatoma protein. J. Biol. Chem. 273:22,708–22,713.
Kolluri, S.K., Weiss, C., Koff, A., and Göttlicher, M. (1999). p27kipl induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13:1742–1753.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dalton, T.P., Kerzee, J.K., Wang, B. et al. Dioxin exposure is an environmental risk factor for ischemic heart disease. Cardiovasc Toxicol 1, 285–298 (2001). https://doi.org/10.1385/CT:1:4:285
Issue Date:
DOI: https://doi.org/10.1385/CT:1:4:285